Newsletter
Digital Health Insights
Expert analysis on longevity, GLP-1 therapies, synbiotics, digital health, and wellness innovation.
Latest issue 2026-10-08 · 5 pieces
Synbiotics
Synbiotics Shift from Aisle to Clinical Pathway
Synbiotics function best when embedded in sequenced clinical pathways rather than sold as standalone shelf products.
2026-10-08 · Read the essay
- 02
Longevity
Biological Age Metrics Operators Can Track Now
Operators must separate measurable clinic signals from longevity marketing when assessing biological age in practice.
- 03
Digital Health
Clinics Get Digital Health That Ships: Records, Workflow, Payment
Digital health succeeds in clinics only when records, daily workflows, and payment processes are built to operate together from day one.
- 04
Equity
Equitable Spread of Diagnostics and Medicines
Equitable distribution of diagnostics and medicines demands deliberate redesign of supply routes, funding pools, and clinic protocols so that every patient encounters the same baseline availability regardless of location or income.
- 05
GLP-1
GLP-1 Beyond Weight Loss: Access, Adherence, and Gut Effects
Clinicians face mounting questions about how to sustain GLP-1 therapy once the initial prescription is written, especially around real access barriers, patient follow-through, and gastrointestinal tolerability.
- 06
Population health
India's Population Health Turn Toward Preventive Reach
Population health efforts across India are moving from isolated programs to coordinated strategies that link clinics with communities for broader coverage.
- 07
Homecare
Nurses Drive Hospital-at-Home via Remote Monitoring
Hospital-at-home programs combined with nurse-run remote monitoring move selected acute care into patient residences while preserving clinical oversight.
- 08
Health economics
Prevention Paywalls: Tracking Who Funds and Who Gains
Prevention spending creates value that rarely returns to the original payer, shifting the economic burden across systems and patients.
